Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Joseph Anthony Dottino, M.D.


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Melendez B, Shah S, Jiang Y, Dottino J, Watson E, Pearce H, Borthwick M, Schmandt RE, Zhang Q, Cumpian K, Celestino J, Fellman B, Yuan Y, Lu KH, Mikos AG, Yates MS. Novel polymer-based system for intrauterine delivery of everolimus for anti-cancer applications. J Control Release. 2021 11 10; 339:521-530. PMID: 34648891; PMCID: PMC8650567.
    Citations:    Fields:    Translation:Animals
  2. Gonzalez R, Havrilesky LJ, Myers ER, Secord AA, Dottino JA, Berchuck A, Moss HA. Cost-effectiveness analysis comparing "PARP inhibitors-for-all" to the biomarker-directed use of PARP inhibitor maintenance therapy for newly diagnosed advanced stage ovarian cancer. Gynecol Oncol. 2020 11; 159(2):483-490. PMID: 32863036.
    Citations: 4     Fields:    Translation:Humans
  3. Dottino JA, Zhang Q, Loose DS, Fellman B, Melendez BD, Borthwick MS, McKenzie LJ, Yuan Y, Yang RK, Broaddus RR, Lu KH, Soliman PT, Yates MS. Endometrial biomarkers in premenopausal women with obesity: an at-risk cohort. Am J Obstet Gynecol. 2021 03; 224(3):278.e1-278.e14. PMID: 32835719; PMCID: PMC7897335.
    Citations: 1     Fields:    Translation:Humans
  4. Dottino JA, He W, Sun CC, Zhao H, Fu S, Rauh-Hain JA, Suidan RS, Lu KH, Giordano SH, Meyer LA. National trends in bowel and upper abdominal procedures in ovarian cancer surgery. Int J Gynecol Cancer. 2020 08; 30(8):1195-1202. PMID: 32616627.
    Citations: 2     Fields:    Translation:Humans
  5. Dottino JA, Rauh-Hain JA. Financial toxicity: An adverse effect worthy of a black box warning? Gynecol Oncol. 2020 02; 156(2):263-264. PMID: 32046838; PMCID: PMC7346986.
    Citations:    Fields:    Translation:Humans
  6. Dottino JA, He W, Sun CC, Zhao H, Fu S, Lu KH, Meyer LA. Centers for Medicare and Medicaid Services' Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) scores and gynecologic oncology surgical outcomes. Gynecol Oncol. 2019 08; 154(2):405-410. PMID: 31208738.
    Citations: 11     Fields:    Translation:Humans
  7. Dottino JA, Moss HA, Lu KH, Secord AA, Havrilesky LJ. U.S. Food and Drug Administration-Approved Poly (ADP-Ribose) Polymerase Inhibitor Maintenance Therapy for Recurrent Ovarian Cancer: A Cost-Effectiveness Analysis. Obstet Gynecol. 2019 04; 133(4):795-802. PMID: 30870286; PMCID: PMC7181403.
    Citations: 9     Fields:    Translation:Humans
  8. Meyer LA, He W, Sun CC, Zhao H, Wright AA, Suidan RS, Dottino J, Alejandro Rauh-Hain J, Lu KH, Giordano SH. Neoadjuvant chemotherapy in elderly women with ovarian cancer: Rates of use and effectiveness. Gynecol Oncol. 2018 09; 150(3):451-459. PMID: 29961559.
    Citations: 16     Fields:    Translation:Humans
  9. Dottino JA, Lu KH. Towards value-based universal Lynch syndrome identification in endometrial cancer patients. Gynecol Oncol. 2016 12; 143(3):451-452. PMID: 27865420.
    Citations:    Fields:    Translation:HumansPHPublic Health
  10. Dottino JA, Hasselblad V, Secord AA, Myers ER, Chino J, Havrilesky LJ. Levonorgestrel Intrauterine Device as an Endometrial Cancer Prevention Strategy in Obese Women: A Cost-Effectiveness Analysis. Obstet Gynecol. 2016 10; 128(4):747-753. PMID: 27607867.
    Citations: 3     Fields:    Translation:Humans
  11. Dickson EL, Vogel RI, Gehrig PA, Pierce S, Havrilesky L, Secord AA, Dottino J, Fader AN, Ricci S, Geller MA. A multi-institutional study of outcomes in stage I-III uterine carcinosarcoma. Gynecol Oncol. 2015 Nov; 139(2):275-82. PMID: 26348313; PMCID: PMC5189638.
    Citations: 6     Fields:    Translation:Humans
  12. Dottino JA, Cliby WA, Myers ER, Bristow RE, Havrilesky LJ. Improving NCCN guideline-adherent care for ovarian cancer: Value of an intervention. Gynecol Oncol. 2015 Sep; 138(3):694-9. PMID: 26072441.
    Citations: 5     Fields:    Translation:Humans
  13. Chi DS, Zivanovic O, Levinson KL, Kolev V, Huh J, Dottino J, Gardner GJ, Leitao MM, Levine DA, Sonoda Y, Abu-Rustum NR, Brown CL, Barakat RR. The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas. Gynecol Oncol. 2010 Oct; 119(1):38-42. PMID: 20609464.
    Citations: 51     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Dottino's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (86)
Co-Authors (1)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.